BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36646383)

  • 1. Twelve-month end point results from the evaluation of the Zilver Vena venous stent in the treatment of symptomatic iliofemoral venous outflow obstruction (VIVO clinical study).
    Hofmann LR; Gagne P; Brown JA; Saunders A; Comerota A;
    J Vasc Surg Venous Lymphat Disord; 2023 May; 11(3):532-541.e4. PubMed ID: 36646383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Final 3-Year Study Outcomes from the Evaluation of the Zilver Vena Venous Stent for the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction (The VIVO Clinical Study).
    Comerota AJ; Gagne P; Brown JA; Segbefia E; Hofmann LV;
    J Vasc Interv Radiol; 2024 Jun; 35(6):834-845. PubMed ID: 38484910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One Year Outcomes of the VIVO-EU Study of Treatment of Symptomatic Iliofemoral Outflow Obstruction with the Zilver Vena Venous Self-Expanding Stent.
    O'Sullivan GJ; Karunanithy N; Binkert CA; Ortega MR; Lichtenberg M; McCann-Brown JA
    Cardiovasc Intervent Radiol; 2021 Dec; 44(12):1930-1936. PubMed ID: 34611732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pivotal Study Evaluating the Safety and Effectiveness of the Abre Venous Self-Expanding Stent System in Patients With Symptomatic Iliofemoral Venous Outflow Obstruction.
    Murphy E; Gibson K; Sapoval M; Dexter DJ; Kolluri R; Razavi M; Black S
    Circ Cardiovasc Interv; 2022 Feb; 15(2):e010960. PubMed ID: 35105153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pivotal Study of Endovenous Stent Placement for Symptomatic Iliofemoral Venous Obstruction.
    Razavi MK; Black S; Gagne P; Chiacchierini R; Nicolini P; Marston W;
    Circ Cardiovasc Interv; 2019 Dec; 12(12):e008268. PubMed ID: 31833414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of venous self-expanding stent placement for iliofemoral venous outflow obstruction.
    Xu H; Tian Y; Zhang J; Sun L; Yang T; Ma T; Wang S; Su X; Zhang W; Hao B
    J Vasc Surg Venous Lymphat Disord; 2021 Sep; 9(5):1178-1184. PubMed ID: 33548554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcomes and technical factors with the Wallstent for treatment of chronic iliofemoral venous obstruction.
    Gagne PJ; Gagne N; Kucher T; Thompson M; Bentley D
    J Vasc Surg Venous Lymphat Disord; 2019 Jan; 7(1):45-55. PubMed ID: 30558730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-Year Outcomes of the Abre Venous Self-Expanding Stent System in Patients with Symptomatic Iliofemoral Venous Outflow Obstruction.
    Black S; Sapoval M; Dexter DJ; Gibson K; Kolluri R; Razavi M; deFreitas DJ; Wang H; Brucato S; Murphy E;
    J Vasc Interv Radiol; 2024 May; 35(5):664-675.e5. PubMed ID: 38336032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of the 50% stenosis criterion for patients undergoing stenting for chronic iliofemoral venous obstruction.
    Jayaraj A; Powell T; Raju S
    J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1408-1415. PubMed ID: 34098125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes following use of a composite Wallstent-Z stent approach to iliofemoral venous stenting.
    Jayaraj A; Noel C; Kuykendall R; Raju S
    J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):393-400.e2. PubMed ID: 32827734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of body mass index on initial presentation and outcomes after stenting for quality of life-impairing chronic iliofemoral venous obstruction.
    Jayaraj A; Powell T; Raju S
    J Vasc Surg Venous Lymphat Disord; 2022 Mar; 10(2):325-333.e1. PubMed ID: 34358674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placement of closed-cell designed venous stents in a mixed cohort of patients with chronic venous outflow obstructions - short-term safety, patency, and clinical outcomes.
    Lichtenberg M; Breuckmann F; Stahlhoff WF; Neglén P; Rick G
    Vasa; 2018 Oct; 47(6):475-481. PubMed ID: 30175948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous stent patency is independent of total stented length in nonthrombotic iliac vein and post-thrombotic venous stenoses.
    Robertson B; Shapiro J; Muck A; Fellner AN; Recht M; Kulwicki A; Broering M; Kuhn B; Muck P
    J Vasc Surg Venous Lymphat Disord; 2023 Mar; 11(2):339-345. PubMed ID: 36007799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technique of stent sizing in patients with symptomatic chronic iliofemoral venous obstruction-the case for intravascular ultrasound-determined inflow channel luminal area-based stenting and associated long-term outcomes.
    Jayaraj A; Thaggard D; Lucas M
    J Vasc Surg Venous Lymphat Disord; 2023 May; 11(3):634-641. PubMed ID: 36731654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-Year Results from the Venovo Venous Stent Study for the Treatment of Iliac and Femoral Vein Obstruction.
    Dake MD; O'Sullivan G; Shammas NW; Lichtenberg M; Mwipatayi BP; Settlage RA;
    Cardiovasc Intervent Radiol; 2021 Dec; 44(12):1918-1929. PubMed ID: 34545448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The initial report on 1-year outcomes of the feasibility study of the VENITI VICI VENOUS STENT in symptomatic iliofemoral venous obstruction.
    Razavi M; Marston W; Black S; Bentley D; Neglén P
    J Vasc Surg Venous Lymphat Disord; 2018 Mar; 6(2):192-200. PubMed ID: 29290601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midterm and Long-Term Outcomes following Dedicated Endovenous Nitinol Stent Placement for Symptomatic Iliofemoral Venous Obstruction: Three- to 5-Year Results of the VIRTUS Study.
    Razavi MK; Gagne P; Black S; Sadek M; Nicolini P; Weinberg I; Marston W;
    J Vasc Interv Radiol; 2022 Dec; 33(12):1485-1491.e1. PubMed ID: 36067976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Braided nitinol stent for chronic iliofemoral venous disease - the real-world BLUEFLOW registry.
    Lichtenberg M; Stahlhoff S; Özkapi A; de Graaf R
    Vasa; 2021 Sep; 50(5):372-377. PubMed ID: 33955794
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcomes and predictors of failure of iliac vein stenting after catheter-directed thrombolysis for acute iliofemoral thrombosis.
    Avgerinos ED; Saadeddin Z; Abou Ali AN; Pandya Y; Hager E; Singh M; Al-Khoury G; Makaroun MS; Chaer RA
    J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):153-161. PubMed ID: 30660580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beneficial role of complex decongestive therapy in patients with symptomatic chronic iliofemoral venous obstruction with phlebolymphedema.
    Jayaraj A; Thaggard D
    J Vasc Surg Venous Lymphat Disord; 2024 Jan; 12(1):101686. PubMed ID: 37714459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.